Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Herceptin
Related studies linked through entity extraction aliases.
Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Prognostic and Predictive Factors for Small Breast Tumors
- Status
- COMPLETED
- Phase
- N/A
Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German Sourced) in Healthy Chinese Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis
- Status
- UNKNOWN
- Phase
- PHASE4
Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
- Status
- SUSPENDED
- Phase
- N/A
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01)
- Status
- COMPLETED
- Phase
- PHASE1